{"id":"W2078126254","doi":"10.2174/1381612013397401","title":"Development of Glucagon-Like Peptide-1-Based Pharmaceuticals as Therapeutic Agents for the Treatment of Diabetes","year":2001,"lang":"en","type":"review","venue":"Current Pharmaceutical Design","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Glucagon-like peptide-2; Incretin; Glucagon-like peptide-1; Enteroendocrine cell; Receptor; Glucagon-like peptide 1 receptor; In vivo; Endocrinology; Pharmacology; Diabetes mellitus; Internal medicine; Medicine; Biology; Endocrine system; Type 2 diabetes; Hormone; Biochemistry; Peptide; Agonist","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007262148,0.001055361,0.002914064,0.0003655725,0.0001600665,0.00003460461,0.0004881386,0.0002273341,0.000483784],"category_scores_gemma":[0.00005486481,0.0006200958,0.001570157,0.000620982,0.0003343566,0.00005461207,0.00007151621,0.0002713234,0.0001127006],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005246266,"about_ca_system_score_gemma":0.0008949775,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":5.123704e-7,"about_ca_topic_score_gemma":1.342653e-7,"domain_scores_codex":[0.9954877,0.0003081914,0.001716692,0.0007813764,0.0007530375,0.0009530289],"domain_scores_gemma":[0.9958584,0.002093698,0.0006618993,0.0007523783,0.0002043286,0.0004293364],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000208007,0.00533862,0.00003331584,0.02087153,0.004777235,0.000005902996,0.00009165158,0.00000659218,0.00002480338,0.0001688486,0.000998212,0.9674753],"study_design_scores_gemma":[0.004641293,0.001300072,0.00001075232,0.005993106,0.02439594,0.0000017386,0.0000136365,0.001289984,0.002624791,0.00002941296,0.9592221,0.0004771721],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006315728,0.9808328,0.006747234,0.00009309645,0.001042406,0.01086569,0.00007115223,0.00007820562,0.0002062552],"genre_scores_gemma":[0.0001924585,0.9920189,0.002756835,0.0001860511,0.000206169,0.003427672,0.000356197,0.0001393737,0.0007163889],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9669981,"threshold_uncertainty_score":0.999625,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3592725044069848,"score_gpt":0.4789353361507858,"score_spread":0.119662831743801,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}